University of Pittsburgh’s Experimental COVID-19 Vaccine Called ‘PittCoVacc’ Works on Mice

University of Pittsburgh School of Medicine researcher scientists have a potential vaccine targeting SARS-CoV-2. Pre-clinical research on mice reveal that the fingerprint-sized patch produces antibodies specific to the novel coronavirus at quantities thought to be sufficient for neutralizing the virus. Recently, when tested in mice, the experimental product known as PittCoVacc generated a surge of antibodies … Continue reading University of Pittsburgh’s Experimental COVID-19 Vaccine Called ‘PittCoVacc’ Works on Mice